BAILARD, INC. Q4 2021 Filing
Filed February 10, 2022
Portfolio Value
$3.1B
Holdings
712
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (712 positions)
| Stock | Value |
|---|---|
LCTXLINEAGE CELL THERAPEUTICS IN | $155K |
OVIDOVID THERAPEUTICS INC | $154K |
—BIOCEPT INC | $152K |
NHSNEUBERGER BERMAN HIGH YIELD | $135K |
ERICERICSSON | $126K |
—BIO-PATH HLDGS INC | $126K |
DNOWNOW INC | $114K |
HBIOHARVARD BIOSCIENCE INC | $104K |
SLDBSOLID BIOSCIENCES INC | $93K |
CTVHELIX ENERGY SOLUTIONS GRP I | $89K |
SANBANCO SANTANDER S.A. | $64K |
CBAYUSDCYMABAY THERAPEUTICS INC | $46K |
PreviousPage 8 of 8